ProKidney Corp.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PROK | PHAR | PRTA | RLMD | PLX | NXTCL.ST | |
|---|---|---|---|---|---|---|
| Market cap | 447.08M | 881.90M | 430.72M | 444.81M | 216.74M | 34.25M |
| P/E (TTM) | — | 38.9 | — | — | 11.7 | — |
| Forward P/E | -1.8 | 69.2 | -6.4 | -10.2 | 4.3 | — |
| Price/book | -0.3 | 2.9 | 1.5 | 2.2 | 3.0 | 0.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −60.37% | −1.90% | −16.77% | +59.77% | +21.17% | −65.80% |
| Today | +4.67% | −3.63% | +2.19% | −2.34% | +3.07% | −6.55% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All PROK news ›ProKidney Corp. (PROK) Discusses Rilparencel Mechanism and Role in Advanced Chronic Kidney Disease Transcript
ProKidney Corp. (PROK) Discusses Rilparencel Mechanism and Role in Advanced Chronic Kidney Disease October 27, 2026 10:30 AM EDT Vamil Divan - Guggenheim Securities, LLC, Research DivisionLin Tsai - Jefferies LLC, Research DivisionJoseph…
Critical Contrast: CytomX Therapeutics (NASDAQ:CTMX) versus ProKidney (NASDAQ:PROK)
Posted by Kim Johansen on Oct 27th, 2026 CytomX Therapeutics (NASDAQ:CTMX – Get Free Report) and ProKidney (NASDAQ:PROK – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the…
ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2026
October 22, 2026 08:00 ET | Source: ProKidney ProKidney Rilparencel Is Associated with a Graft-Adjacent Remodeling Response and Preserved Vascular Integrity in an Immunocompromised Rat CKD ModelAbstract Number: FR-OR044Session Title:…
ProKidney (NASDAQ:PROK) vs. uniQure (NASDAQ:QURE) Financial Survey
Posted by Danessa Lincoln on Oct 14th, 2026 ProKidney (NASDAQ:PROK – Get Free Report) and uniQure (NASDAQ:QURE – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies…
ProKidney (NASDAQ:PROK) Stock Price Down 6% - Here's Why
ProKidney Corp. (NASDAQ:PROK - Get Free Report) shares fell 6% during mid-day trading on Tuesday. The stock traded as low as $1.53 and last traded at $1.57. Approximately 1,593,942 shares were traded during trading, a decline of 5% from…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com2
- marketbeat.com1
- seekingalpha.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.